Argos Therapeutics

Argos Therapeutics, Inc. is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases and transplantation rejection. The company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells - the master switch that turns the immune system on or off.

Type
Public
HQ
Durham, US
Founded
1997
Employees
136 (est)+21%
Argos Therapeutics was founded in 1997 and is headquartered in Durham, US

Argos Therapeutics Locations

Durham, US

Argos Therapeutics Metrics

Argos Therapeutics Summary

Market capitalization

$196 M

Closing share price

$4.75
Argos Therapeutics's latest market capitalization is $196 M.

Argos Therapeutics Market Value History

Argos Therapeutics Online Presence

Argos Therapeutics News

Argos Therapeutics Company Life

You may also be interested in